FOXK2 and congenital myopathy: Our observation that CoQ10 treatment improves the phenotype of muscle development disorders in mice with Foxk2 deficiency provides new insights into its potential treatment prospects in for treating congenital myopathy with ptosis caused by FOXK2 mutations, highlighting the need for further clinical investigation.